Rhumbline Advisers Oric Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 89,247 shares of ORIC stock, worth $855,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,247

Previous 92,702 3.73%

Holding current value

$855,878

Previous $655,000 39.54%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$7.52 - $11.9 $25,981 - $41,114	-3,455 Reduced 3.73%	89,247 $914,000
Q2 2024 Aug 01, 2024	BUY	$6.63 - $12.93 $214,825 - $418,957	32,402 Added 53.73%	92,702 $655,000
Q1 2024 May 09, 2024	BUY	$8.04 - $16.03 $19,263 - $38,407	2,396 Added 4.14%	60,300 $829,000
Q4 2023 Feb 08, 2024	SELL	$5.41 - $9.43 $3,662 - $6,384	-677 Reduced 1.16%	57,904 $532,000
Q3 2023 Nov 09, 2023	BUY	$6.05 - $9.28 $40,389 - $61,953	6,676 Added 12.86%	58,581 $354,000
Q2 2023 Aug 08, 2023	BUY	$4.95 - $8.4 $256,929 - $436,002	51,905 New	51,905 $402,000
Q2 2022 Aug 11, 2022	SELL	$2.7 - $7.07 $104,951 - $274,817	-38,871 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.54 - $16.1 $13,261 - $47,028	2,921 Added 8.13%	38,871 $208,000
Q4 2021 Feb 10, 2022	SELL	$12.01 - $20.3 $4,828 - $8,160	-402 Reduced 1.11%	35,950 $528,000
Q3 2021 Nov 12, 2021	BUY	$15.9 - $25.22 $40,990 - $65,017	2,578 Added 7.63%	36,352 $760,000
Q2 2021 Aug 05, 2021	BUY	$17.37 - $25.34 $196,055 - $286,012	11,287 Added 50.19%	33,774 $597,000
Q1 2021 May 06, 2021	BUY	$23.67 - $36.85 $11,716 - $18,240	495 Added 2.25%	22,487 $551,000
Q4 2020 Feb 10, 2021	BUY	$20.32 - $39.8 $270,418 - $529,658	13,308 Added 153.25%	21,992 $744,000
Q3 2020 Nov 12, 2020	SELL	$19.5 - $31.26 $27,787 - $44,545	-1,425 Reduced 14.1%	8,684 $217,000
Q2 2020 Aug 13, 2020	BUY	$25.68 - $38.12 $259,599 - $385,355	10,109 New	10,109 $341,000

Others Institutions Holding ORIC

# of Institutions

124

Shares Held

66.6M

Call Options Held

7.8K

Put Options Held

700

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $380M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Oric Pharmaceuticals, Inc. Transaction History